<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03754621</url>
  </required_header>
  <id_info>
    <org_study_id>IlSaglik2018-2</org_study_id>
    <nct_id>NCT03754621</nct_id>
  </id_info>
  <brief_title>Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey</brief_title>
  <official_title>What is the Rational Upper Limit for TSH and T4 During First and Second Trimester Pregnancy in West Black Sea Region of Turkey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bartin State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bartin State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physiological changes necessitate the use of pregnancy-specific reference ranges for TSH and
      FT4 to diagnose thyroid dysfunction during pregnancy. Although many centers use fixed upper
      limits for TSH of 2.5 or 3.0 mU/L, this may lead to overdiagnosis or even overtreatment.

      The new guidelines of the American Thyroid Association have considerably changed
      recommendations regarding thyroid function reference ranges in pregnancy accordingly. Any
      hospital or physician that is still using the 2.5 or 3.0 mU/l cut-off for TSH during
      pregnancy should evaluate their own lab-specific cut-offs.

      The investigator's objective is to establish a rational reference range of serum TSH for
      diagnosis of subclinical hypothyroidism in the first and second trimester of pregnant women
      in west Black Sea region in Turkey.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Serum thyroid function tests (including T3, T4, TSH, Anti-TPO) will be obtained from the
      singleton pregnancies in first and second trimester to determine the local specific normal
      ranges.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Anticipated">July 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>TSH</measure>
    <time_frame>Day 1</time_frame>
    <description>Serum TSH (mU/I)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Thyroid</condition>
  <condition>Thyroid Dysfunction</condition>
  <condition>Hypothyroidism</condition>
  <condition>Pregnancy Early</condition>
  <arm_group>
    <arm_group_label>Pregnants</arm_group_label>
    <description>400 pregnant women with a singleton pregnancy, free of pre-existing thyroid disease, that do not use thyroid interfering medication, that did not undergo IVF treatment and are TPOAb negative. Serum thyroid functions tests will be obtained on the first visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum thyroid functions tests</intervention_name>
    <description>Serum TSH, fT3, fT4 and anti-TPO</description>
    <arm_group_label>Pregnants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Turkish pregnant women living in Bartin Region of Turkey
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancy

          -  Free of pre-existing thyroid disease

          -  That do not use thyroid interfering medication

          -  That did not undergo IVF treatment

          -  TPOAb negative

        Exclusion Criteria:

          -  Adolescent pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murat Yassa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bartin State Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Murat Yassa, MD</last_name>
    <phone>+905335106312</phone>
    <email>murat.yassa@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bartin State Hospital</name>
      <address>
        <city>Bartin</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Murat Yassa, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Korevaar TIM. The upper limit for TSH during pregnancy: why we should stop using fixed limits of 2.5 or 3.0 mU/l. Thyroid Res. 2018 May 21;11:5. doi: 10.1186/s13044-018-0048-7. eCollection 2018.</citation>
    <PMID>29942352</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>November 23, 2018</study_first_submitted>
  <study_first_submitted_qc>November 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2018</study_first_posted>
  <last_update_submitted>April 21, 2019</last_update_submitted>
  <last_update_submitted_qc>April 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bartin State Hospital</investigator_affiliation>
    <investigator_full_name>Murat Yassa</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>TSH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

